NASDAQ:XERS Shareholder Notice: Investigation over Possible Securities Laws Violations by Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. is under investigation concerning potential violations of securities laws in connection with certain financial statements.
View full press release